Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E D Milligan

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Neuroscience Letters|August 9, 2023
The FDA-approved compound, pramipexole and the clinical-stage investigational drug, dexpramipexole, reverse chronic allodynia from sciatic nerve damage in mice, and alter IL-1β and IL-10 expression from immune cell cultureJ E Sanchez, S Noor, M S Sun, et al.
Brain, Behavior, and Immunity|October 7, 2008
Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapyEvan Sloane, A Ledeboer, W Seibert, et al.
Journal of the Peripheral Nervous System : JPNS|January 31, 2002
Sciatic inflammatory neuritis (SIN): behavioral allodynia is paralleled by peri-sciatic proinflammatory cytokine and superoxide productionL S Gazda, E D Milligan, M K Hansen, et al.
The European Journal of Neuroscience|November 5, 2004
Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in ratsE D Milligan, V Zapata, M Chacur, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Neuroscience Letters|August 9, 2023
The FDA-approved compound, pramipexole and the clinical-stage investigational drug, dexpramipexole, reverse chronic allodynia from sciatic nerve damage in mice, and alter IL-1β and IL-10 expression from immune cell cultureJ E Sanchez, S Noor, M S Sun, et al.
Brain, Behavior, and Immunity|October 7, 2008
Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapyEvan Sloane, A Ledeboer, W Seibert, et al.
Journal of the Peripheral Nervous System : JPNS|January 31, 2002
Sciatic inflammatory neuritis (SIN): behavioral allodynia is paralleled by peri-sciatic proinflammatory cytokine and superoxide productionL S Gazda, E D Milligan, M K Hansen, et al.
The European Journal of Neuroscience|November 5, 2004
Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in ratsE D Milligan, V Zapata, M Chacur, et al.
Pageof 2